Press Release Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA Aug 24
Press Release Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Aug 13